Clinical trial
Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia
NCT07513038 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia
- Lead sponsor
- Boston Children's Hospital
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- August 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.